Skip to main content
George A. Xixis

George A. Xixis

Practice areas:

Life Sciences & Biotechnology, Intellectual Property, Contracts & Agreements, Licensing, Patent Application, Patent Infringement

About Me

I have  particular expertise in the area of short- and long-term strategic planning for growing biopharmaceutical companies. This includes the cost-effective construction of potentially complex IP portfolios, as well as advising on and implementing value maximization strategies, including worldwide litigation and licensing

More 

Languages Spoken: French, Greek

Photos and Videos

1429964 1263242356

Practice Areas

Licensed since 1994

  1. Life Sciences & Biotechnology: 30%
    22 years
  2. Intellectual Property: 20%
    22 years
  3. Licensing: 15%
    22 years
  4. Contracts & Agreements: 15%
    22 years
  5. Other: 20%
  6. More 

Payment

Payment Types:

Check, Credit Card

Attorney Endorsements

3 total 

  • Stephen A Gould

    I strongly endorse George Xixis, whom I have had the pleasure of working with for 6 years. Our clients have benefited greatly from George's quick grasp of the intellectual property issues arising out of a particular invention and/or product, his practical approach to patent and copyright protection for these inventions and products and his strategy for protecting these patents when infringement issues arise. He has significant experience working with all stages of technology and life sciences companies, from start-ups through mature businesses with large and intricate patent portfolios. He is a true team player, strategic thinker, proactive to our clients' needs and has a great sense of humor.

    More 

    Stephen Gould Business Attorney
    Relationship: Co-worker

  • No photo

    I endorse this lawyer's work. I worked with George both when he was in-house at Curagen and I was General Counsel at Abgenix, and during his tenure as a partner at Nutter McClennen & Fish. He is a fine legal analyst with a practical approach to problem-solving and a nuanced understanding of the business context in which complex problems must be addressed. He is a pleasure to work with, whether as a colleague or as trusted outside counsel, and he can be counted on for timeliness and excellent results. I would not hesitate to recommend him for any matter involving intellectual property issues.

    More 

    Susan Thorner Business Attorney
    Relationship: Worked together on matter

Contact Info

White and Williams LLP

99 Summer Street
Boston, MA, 02110-1248

Resume

License
StateStatusAcquiredUpdated
MAActive200504/14/2015
DCActive 199905/25/2015
NYCurrently registered 199403/13/2015

Professional Misconduct

We have not found any instances of professional misconduct for this lawyer.
Avvo Contributions
Legal Answers
Awards
Award NameGrantorDate Granted
Assoc. Managing Editor Brooklyn Law ReviewBrooklyn Law School1993
Jessup Int'l Law Moot Court - Regional ChampionInternational Law Students Association1993
Moot Court Honor SocietyBrooklyn Law School1992
Richardson ScholarBrooklyn Law Schol1991

Work Experience
TitleCompany NameDuration
CounselWhite and Williams LLP2015 - Present
Division Counsel R&D & LicensingAbbott Laboratories/AbbVie Inc.2012 - 2014
PartnerNutter McClennen & Fish2003 - 2012
VP Business DevelopmentAmdec, LLC2002 - 2003
Chief IP CounselCuragen Corporation1998 - 2002
AssociateKaye Scholer1996 - 1998
AssociateFish & Neave1993 - 1996

Associations
Association NamePosition NameDuration
Joslin Diabetes Center - BostonMember I.P. Review Committee2015 - Present
American Intellectual Property Law AssociationSpecial Committee on the FDA2008 - 2012
American Intellectual Property Law AssociationPatent Litigation Committee Member2008 - 2012
American Intellectual Property Law AssociationAnti-Trust Law Committee, Member2008 - 2012
Boston Harbor AngelsMember and Co-Chair Life Sciences Screening Committee2008 - 2012
Ameircan Intellectual Property Law Association (AIPLA)Member2001 - 2012
American Psychological SocietyMember2000 - 2009
Association of Coproprate CounselMember1998 - 2002
District of Columbia BarMember1998 - Present
American Bar AssociationMember1994 - Present

Legal Cases
Case NameOutcome
DANA-FARBER CANCER INSTITUTE, INC. v. UPSTATE BIOTECHNOLOGY INCSettlement and Dismissal
PHARMACIA & UPJOHN COMPANY v. MYLAN PHARMACEUTICALS, INCDistrict Court Decision Affirmed
Barris v. HamiltonDefendants motions to dismiss granted

See all Legal Cases 

Publications
Publication NameTitleDate
Intellectual Property Licensing Strategies, 2012 ed.: Leading Lawyers on Analyzing Trends in IP Licensing and Drafting Effective Agreements (Inside the Minds)Current Trends in IP Licensing: Tools for Licensees and Licensors”2012
Mass High TechGuest Commentary: Merck decision promotes development, but will not reduce costs2005
Pharmaceutical ExecutivePrescription Drug Law Won't Lower Prices2004
New England In-House MagazineCreating Competitive Advantages through an Effective IP Portfolio2004
The Boston GlobeA LITTLE VICTOR POSES NO GREAT THREAT, VICTORIA2003
Journal of BioLaw & BusinessIntellectual Property Due Diligence: A Cost-Benefit Methodology for Evaluating Assets1999
Journal of Proprietary RightsSpecial Verdicts in Patent Cases: A critical but underused alternative1998

Education
School NameMajorDegreeGraduated
Brooklyn Law SchoolLawJD - Juris Doctor1993
New York UniversityPsychologyMA - Masters1990
Massachusetts Institute of TechnologyCognitive ScienceSB1987
Massachusetts Institute of TechnologyBiologySB1987

Speaking Engagements
Conference NameTitleDate
Bio Process InternationalDefending Biosimilar Competition: BioProcess IP Protection2010
Balancing Daunting and Conflicting Disclosure Requirements: A Case StudyDisclosure Issues affecting Drug Companies2008
Financing Technology EnterprisesFInancing Technology Enterprises - CLE2007
Invention to Venture Forum (2nd Annual) - Workshops in Technology EntrepreneurshipIssues in intellectual property - Navigating the Minefield2006
8th Annual MASS Opportunities Biotechnology Investment ConferenceDealmaking and Exits: Structuring Deals in the Current Environment2006
Stem Cell Research ChallengesStem Cell Intellectual Property: The WARF Patents and Recent Decisions2005
Mass BioTranslational Research: From Bench to Bedside2004
Intellectual Property Rights: a Global Perspective for the Drug IndustrySEQUENCING THE GENOME - Intellectual Property Implications2000